Chu Yong, Xu Ming-Xia, Lü Ding
Pharmacy School of West China, Sichuan University, Chengdu 610041, China.
Yao Xue Xue Bao. 2004 Nov;39(11):904-9.
Design, synthesis and activity study of novel antifungal triazoles.
The structures of two lead-compounds miconazole and itrconazole were modified on the basis of SAR studied by our group and reported in the literature and their antifungal activities in vitro were tested by standard program.
Twelve 1-(1H-1, 2, 4-triazole-1-yl) -2-( 2, 4-difluorophenyl)-3-substituted amino-2-propanol compounds and thirteen 2-substituted phenyl-5-(1H-1, 2, 4-triazole-1-methyl ) 5-( 2, 4-difluorophenyl)-N-substituted oxazolidine compounds were synthesized and confirmed by 1HNMR and MS. In vitro inhibitory tests showed that most of them have more or less inhibitory effects on C. albicans and some inhibit S. cerevisiae also. Especially the effects of A10, A12 and A13 on C. albicans were more potent than (or equal to) that of fluconazole or itraconazole.
Compounds A10, A12 and A13 are worthy to be intensively studied.
新型抗真菌三唑类化合物的设计、合成及活性研究。
在本课题组研究并在文献中报道的构效关系基础上,对两种先导化合物咪康唑和伊曲康唑的结构进行修饰,并通过标准程序测试其体外抗真菌活性。
合成了12个1-(1H-1,2,4-三唑-1-基)-2-(2,4-二氟苯基)-3-取代氨基-2-丙醇类化合物和13个2-取代苯基-5-(1H-1,2,4-三唑-1-甲基)-5-(2,4-二氟苯基)-N-取代恶唑烷类化合物,并通过1HNMR和MS进行了确证。体外抑制试验表明,它们中的大多数对白色念珠菌或多或少有抑制作用,有些对酿酒酵母也有抑制作用。特别是A10、A12和A13对白色念珠菌的作用比氟康唑或伊曲康唑更强(或相当)。
化合物A10、A12和A13值得深入研究。